Zlio Medical AI: Drug Discovery & Biology https://medical.zlio.com/Medical ai news, deduplicated. Zlio is a free, non-commercial project.MindWalk signs multi-year AI drug discovery deal with Teva Australiahttps://news.google.com/rss/articles/CBMi5AFBVV95cUxPakRHNzA5ZVpNc0dPQ3FpWTM3UWtjUkNmMXVaNTFYWHdsaTk4UDEwQWdiZXpuTDZhZTZKLW5hVVZhNjJhN2J3NXZkZENVU0tmbXd2eWxhd3ZMV3pxOUxnNW1iVFdZLWZUTDRaMEsyejNjNERjZW9xTnRXVmN5a2NnYXJ3aUtubTVrZWw5bG9BOU1nZEJmMTNyQi01dVd1dnY1UjZZaTVMcWRCdEdMcUZFQmRDSXZBbHgzT3EtOWdJS19ocTBSZXc1UDh6R3JZV3JTVVlTTUJReV9WZ3lUdXVYeEFfYUY?oc=5 zlio-42Thu, 05 Nov 2026 01:37:00 GMT MindWalk (NASDAQ:HYFT) signed a multi-year agreement with Teva Australia covering its AI drug discovery platform, Kalkine reports.Pharma CEOs call AI curing cancer in a decade 'nonsense'https://news.google.com/rss/articles/CBMidkFVX3lxTE4tZVNxckNXbFdhUEs2cFpUbDBUMzlVZV9vTTVVUjVGUnhVUDZiMHptUXJXUFJKU21PMTlGVVF0clFLOWx3SnNxSnRtZHFCaFo0bGZyZ2pwdFZSN3ZpYXdSMXdqOGE2czBQT1FDZTNBN3NGVTRRQVE?oc=5 zlio-90Thu, 05 Nov 2026 01:06:00 GMT Pharma CEOs pushed back on Silicon Valley claims, saying AI curing cancer within a decade is 'nonsense' and that 50 AI firms have yet to produce a single drug.Algorae expands pharma portfolio, validates AI drug discovery platformhttps://news.google.com/rss/articles/CBMizgFBVV95cUxPd0E3c0hydHdVNU9jUkxLQm5DLUpMVWl6THVzaWtqWTdyc2JIOVBKbnJhaXFpZ09vLUZ2QnZLbG16bUFVanNNbkRwWDd0LU9UR0M5TndRdUtTSnZ2T2RzbnNVV0lnd1M4bFc0ckJDSmdNYXV2ZlljMXpYQTV4U0dUQjlDU0NPcGtTU1lBNy02d0Fub2t6aGhkTHlmSFdTemdsX2VaekRBb1BCaWVTTXZmVmpwSWVuTjlVd2JjTktVWkxMTnZXVTgtSkF5UVM3dw?oc=5 zlio-36Wed, 04 Nov 2026 23:07:07 GMT Algorae expanded its pharmaceutical portfolio and validated its AI drug discovery platform, according to TipRanks.UCB taps Cradle's AI platform for antibody discovery projectshttps://www.unite.ai/ucb-adds-cradles-ai-platform-to-antibody-discovery-projects zlio-87Wed, 04 Nov 2026 22:05:02 GMT Cradle and UCB announced a strategic collaboration to use Cradle's AI protein design and engineering platform in selected UCB antibody discovery projects, from hit generation through lead optimization and preclinical readiness.Anthropic says Claude helped map bacterial and phage vault proteinshttps://www.unite.ai/anthropic-uses-claude-to-show-bacterial-and-phage-proteins-form-vaults zlio-84Wed, 04 Nov 2026 20:12:05 GMT Anthropic reported that prokaryotic and bacteriophage relatives of the major vault protein assemble into vault particles in E. coli; Claude helped map one bacteriophage-derived shell at 3.2 angstroms.Recursion reports Phase 2 data, chair appointment, Q3 resultshttps://news.google.com/rss/articles/CBMigAFBVV95cUxQMFltNVJzNGtNVHo3Y19nNGUzdUhFOHdKelZHSWhLbm5HbWp3N1A1NHBKcWtvMzE5cFRrOHlFNmo5UVNwQ2ViQWJ2NjVLN0dBSXl6Wl9PVHFrY0t6MGdrZ1hQTklkY1QxdGl3ZDZtdy11OVpGVUdBNk5vdXVtb2Rocg?oc=5 zlio-40Wed, 04 Nov 2026 18:27:55 GMT Coverage examines Recursion's Phase 2 trial results, new chair appointment and Q3 earnings, plus Nvidia's investment in its AI drug discovery platform.nPhase raises $30M to expand AI-native clinical data platformhttps://www.fiercebiotech.com/cro/nphase-rakes-30m-expand-ai-native-clinical-data-platform zlio-12Wed, 04 Nov 2026 13:21:56 GMT nPhase raked in $30 million to expand its AI-native clinical data platform.STAT+ looks at biotech startups skipping AI for drug discoveryhttps://www.statnews.com/2026/11/04/the-biotech-startups-skipping-ai-for-drug-discovery-ai-prognosis zlio-11Wed, 04 Nov 2026 13:01:33 GMT In AI Prognosis, STAT examines biotech startups that do not believe drug discovery is where AI can make the biggest difference, and where they apply it instead.Google DeepMind releases agentic cheminformatics tools on Antigravity for drug discoveryhttps://deepmind.google/blog/agentic-cheminformatics-with-google-antigravity zlio-77Tue, 03 Nov 2026 17:01:49 GMT Google DeepMind says Google Antigravity and its Cheminformatics Skills accelerate drug discovery workflows, search compounds and propose novel rigidified macrocycles.